General form of registration statement for all companies including face-amount certificate companies

Accrued Expenses

v3.23.1
Accrued Expenses
3 Months Ended 12 Months Ended
Mar. 31, 2023
Dec. 31, 2022
Payables And Accruals [Abstract]    
Accrued Expenses
 
3.
ACCRUED EXPENSES
As of March 31, 2023 and December 31, 2022, accrued expenses consisted of the following:
 
    
March 31,
    
December 31,
 
    
2023
    
2022
 
Bonus
   $ 1,409,860      $ 1,094,582  
Professional fees
     709,454        332,589  
Research and development costs
     357,469        516,961  
Other
     162,251        159,269  
    
 
 
    
 
 
 
Total accrued expenses
   $ 2,639,034      $ 2,103,401  
    
 
 
    
 
 
 
 
3.
ACCRUED EXPENSES
As of December 31, 2022 and 2021, accrued expenses consisted of the following:
 
    
December 31,
    
December 31,
 
    
2022
    
2021
 
Bonus
   $ 1,094,582      $ 384,750  
Professional fees
     332,589        380,277  
Research and development costs
     516,961        268,140  
Deferred compensation to former officers
     —          111,271  
Other
     159,269        41,157  
    
 
 
    
 
 
 
Total accrued expenses
   $ 2,103,401      $ 1,185,595  
    
 
 
    
 
 
 
Deferred Compensation Agreements
As of December 31, 2022 and December 31, 2021, the Company had $0 and $111,271, respectively, of deferred compensation due to certain employees and officers of the Company pursuant to deferred compensation agreements executed during fiscal 2020 and 2019 as part of a non-qualified deferred compensation plan. Pursuant to the deferred compensation agreements, the employees had deferred a portion of their annual base salary to be paid upon a Qualified Fund Raising. The Qualified Fund Raising was achieved during July 2021. Upon this event, the employees’ salaries were increased up to the market rates set forth in their respective agreements, and all amounts were paid to the employees. The remaining deferred compensation balance as of December 31, 2021 relates to amounts incurred for employees who were no longer with the Company as of the payout date. During the year ended December 31, 2021, the Company accrued $193,379 in deferred compensation. The Company paid $457,749 in cash and issued 268,769 options with a total fair value of $296,264 during the year ended December 31, 2021, to settle a portion of the deferred compensation balance totaling $743,167. The fair value of the options issued in excess of the deferred compensation balance settled totaling $10,846 was recorded as stock-based compensation expense which is presented within general and administrative expenses on the statement of operations for the year ended December 31, 2021.
Accrued Bonus
During the year ended December 31, 2022 and 2021, the Company accrued $1,094,582 and $384,750, respectively, in bonus expense relating to employees and officers of the Company. On April 16, 2021, the 2020 accrued bonus balance was settled by issuance of 713,536 stock options with a total fair value of $786,531. The fair value of the options issued in excess of the accrued bonus balance totaled $6,531 and was recorded as stock-based compensation expense which is presented within general and administrative expenses on the statement of operations for the year ended December 31, 2021. The 2021 accrued bonus was paid in cash in August of 2022.